Appraisal of Surelease Clear E-7–19040, an Ethylcellulose Aqueous Dispersion, as a Release Modifier for the Hydrophilic Core

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY Journal of Pharmaceutical Innovation Pub Date : 2022-11-04 DOI:10.1007/s12247-022-09693-3
Pramod Parshuramkar, Deepak Khobragade, Pranita Kashyap
{"title":"Appraisal of Surelease Clear E-7–19040, an Ethylcellulose Aqueous Dispersion, as a Release Modifier for the Hydrophilic Core","authors":"Pramod Parshuramkar,&nbsp;Deepak Khobragade,&nbsp;Pranita Kashyap","doi":"10.1007/s12247-022-09693-3","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This study evaluated the efficacy of ethylcellulose aqueous dispersion type B (surelease clear E-7–19040) in modifying the drug release from the hydrophilic cores. Because of its ideal physicochemical and biological properties for the controlled-release formulation, Pindolol was selected as the model drug.</p><h3>Methods</h3><p>The final modified-release drug product comprises the immediate-release loading dose and the controlled-release maintenance dose. The tablet formulation was designed to have a seal-coated hydrophilic core with 75% of the drug, followed by a controlled-release polymer coating, immediate-release drug coating with 25% of the drug, followed by a color film coating.</p><h3>Results</h3><p>The controlled-release polymer coating was the critical step to achieving the desired product characteristics. During the coating of aqueous polymer dispersions, the adjustment of the controlled-release polymer to the pore former ratio, the control of the manufacturing process parameters, and the curing conditions are vital to developing a robust and stable end product. The final drug product achieved a targeted drug release profile in the selected dissolution method without a dose-dumping effect in the presence of alcohol and was unaffected by the accelerated stability study condition.</p><h3>Conclusion</h3><p>The ethylcellulose aqueous dispersion type B is very effective in modulating the release of hydrophilic drug core for achieving a desired drug release profile as per the drug product’s quality target product profile and the material of choice for the organic solvent-free, eco-friendly, controlled-release polymer coating system.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"18 3","pages":"923 - 933"},"PeriodicalIF":2.7000,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-022-09693-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose

This study evaluated the efficacy of ethylcellulose aqueous dispersion type B (surelease clear E-7–19040) in modifying the drug release from the hydrophilic cores. Because of its ideal physicochemical and biological properties for the controlled-release formulation, Pindolol was selected as the model drug.

Methods

The final modified-release drug product comprises the immediate-release loading dose and the controlled-release maintenance dose. The tablet formulation was designed to have a seal-coated hydrophilic core with 75% of the drug, followed by a controlled-release polymer coating, immediate-release drug coating with 25% of the drug, followed by a color film coating.

Results

The controlled-release polymer coating was the critical step to achieving the desired product characteristics. During the coating of aqueous polymer dispersions, the adjustment of the controlled-release polymer to the pore former ratio, the control of the manufacturing process parameters, and the curing conditions are vital to developing a robust and stable end product. The final drug product achieved a targeted drug release profile in the selected dissolution method without a dose-dumping effect in the presence of alcohol and was unaffected by the accelerated stability study condition.

Conclusion

The ethylcellulose aqueous dispersion type B is very effective in modulating the release of hydrophilic drug core for achieving a desired drug release profile as per the drug product’s quality target product profile and the material of choice for the organic solvent-free, eco-friendly, controlled-release polymer coating system.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乙基纤维素水分散体Surelease Clear E-7-19040作为亲水性核心脱模剂的评价
目的 本研究评估了乙基纤维素水分散液 B 型(surelease clear E-7-19040)在改变亲水芯药物释放方面的功效。由于吲哚洛尔具有理想的物理化学和生物学特性,因此被选为控释制剂的模型药物。片剂配方的设计是先将 75% 的药物密封包衣在亲水性片芯上,然后包衣控释聚合物,再将 25% 的药物包衣在速释药物上,最后包衣彩膜。在水性聚合物分散体的包衣过程中,调整控释聚合物与前孔器的比例、控制生产工艺参数和固化条件对于开发出坚固稳定的最终产品至关重要。结论 B 型乙基纤维素水分散体在调节亲水性药物核心的释放方面非常有效,可根据药物产品的质量目标实现理想的药物释放曲线,是无有机溶剂、环保型控释聚合物包衣系统的首选材料。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
期刊最新文献
An Analysis of FDA Warning Letter Citations from 2019-2023 Ocular Delivery of Itraconazole Loaded Leciplex to Treat Fungal Infection Formulation, Evaluation, Factorial Optimization, and In-Silico Study of Eplerenone Loaded Pectin Nanoparticles: A New Approach to the Proliferation of Human Skin Fibroblasts for Wound Healing A Novel Mesalamine Loaded Hybrid Nanoparticle-in-Microparticle for Colon Targeting: In-vitro and In-vivo Investigations Editorial: Innovation Exists in Many Areas of Pharmaceutical Development and Commercialization
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1